Back to Search
ZUHRE TUTUNCU, M.D.
M.D.
Rheumatology Physician
NPI: 1962435305IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
A78495(CA)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
OTHER
Class of 1986
Research & Publications (12)
Rheumatic disease in the elderly: rheumatoid arthritis.
PMID 17367692·Rheum Dis Clin North Am·2007
6-review
Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?
PMID 16414968·Ann Rheum Dis·2006
4-observational
Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents.
PMID 16142749·Arthritis Rheum·2005
8-other
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
PMID 18381786·J Rheumatol·2008
4-observational
Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study.
PMID 17872672·Can Fam Physician·2007
6-review
The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.
PMID 17216680·J Rheumatol·2007
4-observational
Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data.
PMID 16774693·Arthritis Res Ther·2006
6-review
Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.
PMID 16763453·Curr Opin Rheumatol·2006
6-review
A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.
PMID 16331761·J Rheumatol·2005
2-rct
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
PMID 15818699·Arthritis Rheum·2005
3-trial
Disease measures in evaluating the effect of anti-TNF therapy and predicting clinical outcome.
PMID 15103044·Rheumatology (Oxford)·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 501 WASHINGTON ST
SAN DIEGO, CA 92103 - Phone
- (619) 278-3300
Quick Facts
- NPI
- 1962435305
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 12
Are you this provider?
Claim Your Profile